Silberman David
SEC CIK 1867998 · EDGAR
Most active insiders at CGEN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Levine Zurit | SVP, Business Development | — | $83.4K |
| 2 | Ophir Eran | Pres, CEO, Dir | — | $42.9K |
| 3 | Kredo Russo Sharon | SVP, Research, Discovery | — | — |
| 4 | Mahler Michelle | Chief Medical Off | — | — |
| 5 | Perry Eran | Dir | — | — |
| 6 | Halevy Gilead | Dir | — | — |
| 7 | Livnat Savitzky Kinneret | Dir | — | — |
| 8 | Hukkelhoven Mathias | Dir | — | — |
| 9 | Silberman David | CFO | — | — |
| 10 | ZWEIFACH SANFORD S | Dir | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-30 16:11 | 2026-07-29 | CGEN | COMPUGEN LTD | Silberman David | CFO | A - Grant | $0.00 | +19.5K | 55.0K | +55% | $0 |
| 2024-01-08 | 2024-01-04 | ORMP | ORAMED PHARMACEUTICALS INC. | Silberman David | CFO | A - Grant | — | +136.5K | 366.5K | +59% | — | |
| 2023-05-31 | 2023-05-26 | ORMP | ORAMED PHARMACEUTICALS INC. | Silberman David | CFO | A - Grant | — | +24.5K | 230.0K | +12% | — | |
| 2023-04-20 | 2023-04-17 | ORMP | ORAMED PHARMACEUTICALS INC. | Silberman David | CFO | A - Grant | — | +97.5K | 205.5K | +90% | — | |
| 2022-08-01 | 2022-07-28 | ORMP | ORAMED PHARMACEUTICALS INC. | Silberman David | CFO | A - Grant | — | +39.0K | 108.0K | +57% | — | |
| D | 2022-01-05 | 2022-01-03 | ORMP | ORAMED PHARMACEUTICALS INC. | Silberman David | CFO | A - Grant | — | +19.0K | 69.0K | +38% | — |
| D | 2021-09-02 | 2021-09-01 | ORMP | ORAMED PHARMACEUTICALS INC. | Silberman David | CFO | A - Grant | $0.00 | +50.0K | 50.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations